A Proteomics Signature of NASH - Non-Invasive Assessment of Nonalcoholic Fatty Liver Disease

Explore the latest advancements in proteomics for diagnosing and monitoring nonalcoholic steatohepatitis (NASH) in this comprehensive webinar presented by Dr. Arun Sanyal. Delve into the global prevalence of nonalcoholic fatty liver disease (NAFLD) and the urgent need for non-invasive diagnostic tools. Learn about the development and validation of proteomics-based models for assessing key liver biopsy components and at-risk NASH. Discover how these innovative "liquid biopsy" techniques could revolutionize NAFLD assessment, potentially replacing invasive liver biopsies. Gain insights into ongoing clinical trials, disease progression, and effective strategies for managing NASH. Engage with cutting-edge research on serum protein profiling and its implications for diagnosis, prognosis, and monitoring of NAFLD and NASH.